Cargando…
Time from last chemotherapy to death and its correlation with the end of life care in a referral hospital
BACKGROUND: A substantial number of cancer patients receive chemotherapy until the end of life (EoL). Various factors have been shown to be associated with receipt of chemotherapy until near death. In this study, we determine our average time from last chemotherapy to death (TLCD) and explore differ...
Autores principales: | Karim, Syed Mustafa, Zekri, Jamal, Abdelghany, Ehab, Dada, Reyad, Munsoor, Husna, Ahmad, Imran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4363852/ https://www.ncbi.nlm.nih.gov/pubmed/25810576 http://dx.doi.org/10.4103/0971-5851.151792 |
Ejemplares similares
-
Neoadjuvant Chemotherapy With Capecitabine Plus Cisplatin in Patients With Locally Advanced Nasopharyngeal Cancer: Case Series Study
por: Dada, Reyad, et al.
Publicado: (2016) -
Chemotherapy for small cell lung cancer: a comprehensive review
por: Karim, Syed Mustafa, et al.
Publicado: (2012) -
Breaking Cancer Bad News to Patients With Cancer: A Comprehensive Perspective of Patients, Their Relatives, and the Public—Example From a Middle Eastern Country
por: Zekri, Jamal, et al.
Publicado: (2016) -
The anti-tumour effects of zoledronic acid
por: Zekri, Jamal, et al.
Publicado: (2014) -
Redefining Precision Management of r/r Large B-Cell Lymphoma: Novel Antibodies Take on CART and BMT in the Quest for Future Treatment Strategies
por: Dada, Reyad
Publicado: (2023)